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Abstract
Background: No study has compared the bothersomeness of all lower urinary tract
symptoms (LUTS) using a population-based sample of adults. Despite this lack of evi-
dence, investigators have often cited their LUTS of interest as the ‘‘most bothersome’’ or
‘‘one of the most bothersome.’’
Objective: To compare the population- and individual-level burden of LUTS in men and
women.
Design, setting, and participants: In this population-based cross-sectional study, ques-
tionnaires were mailed to 6000 individuals (18–79 yr of age) randomly identiﬁed from
the Finnish Population Register.
Outcome measurements and statistical analysis: The validated Danish Prostatic Symp-
tom Score questionnaire was used for assessment of bother of 12 different LUTS. The age-
standardized prevalence of at least moderate bother was calculated for each symptom
(population-level burden). Among symptomatic individuals, the proportion of affected
individuals with at least moderate bother was calculated for each symptom (individual-
level bother).
Results and limitations: Atotal of3727 individuals (62.4%)participated (53.7%female). The
LUTSwith the greatest population-level burdenwere urgency (7.9%with at least moderate
bother), stress urinary incontinence (SUI) (6.5%), nocturia (6.0%), postmicturition dribble
(5.8%), andurgencyurinary incontinence (UUI) (5.0%). Burden fromincontinence symptoms
was higher inwomen thanmen, and the opposite was true for voiding and postmicturition
symptoms.At the individual level,UUIwas themostbothersomeforbothgenders.Although
the response proportion was high, approximately a third did not participate.
Conclusions: Both men and women with UUI report moderate or major bother more
frequently than individuals with other LUTS. At the population level, the most prevalent
bothersome symptoms are urgency, SUI, and nocturia.
Patient summary: Urinary urgency was the most common troubling symptom in a large
population-based study; however, for individuals, urgency incontinence was the most
likely to be rated as bothersome.
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Lower urinary tract symptoms (LUTS) are divided into three
groups: storage symptoms (daytime urinary frequency,
nocturia, urinaryurgency, andurinary incontinence), voiding
symptoms (slow stream, splitting or spraying, intermittent
stream, hesitancy, straining, and terminal dribble), and
postmicturition symptoms (feeling of incomplete emptying
and postmicturition dribble) [1]. These symptoms have a
major impact on health-related quality of life [2] and are
associated with substantial personal and societal expendi-
tures [3]. Because LUTS are associated both with age and
obesity [4,5], the population burden of these conditions is
likely to increase with future demographic shifts.
Symptom bother increases as the number of symptoms
increases and as symptoms become more severe [6].
However, the symptom impact is not well defined by their
frequency alone [3]. Assessment of the bother of symptoms
is of key clinical relevance because it relates to both quality-
of-life impairment and treatment seeking [7,8]. Conse-
quently, clinical practice guidelines suggest that only those
reporting bothersome symptoms should be targeted for
intervention, and watchful waiting is appropriate for those
with minimal symptoms [3,9].
Investigators have often described their LUTS of interest
as the ‘‘most bothersome’’ or ‘‘one of the most bothersome’’
[10–13]. Despite these claims, very few studies have
evaluated the relative degree of bother across all LUTS,
and none have attempted to establish the most bothersome
LUTS in a population-based study of both genders and all
adult ages [14–17]. From the population perspective, the
symptom with the greatest burden is the most prevalent
bothersome symptom. From the individual perspective, the
symptom with the greatest burden is simply the symptom
most likely to be rated as bothersome among the affected.
Thus the purpose of this analysis is to compare the degree of
bother of major LUTS in both men and women 18–79 yr of
age from both the population and individual perspectives.
2. Methods
2.1. The Finnish National Nocturia and Overactive
Bladder Study
The Finnish National Nocturia and Overactive Bladder Study cohort
comprises a population-based sample of men and women 18–79 yr of
age in Finland. Its aim is to assess the prevalence, natural history, impact,
and risk factors of urinary symptoms at the population level. Detailed
study procedures have been published [18–20]. Brieﬂy, in 2003–2004,
questionnaires were mailed to individuals randomly identiﬁed from the
Population Register Centre of Finland. Stratiﬁcation by age was used in
individual selection with oversampling of younger age groups to ensure
an adequate number of individuals with urinary storage symptoms in
each age group [18]. The questionnaire gathered information on
frequency and bother of LUTS, quality of life, numerous conditions
and medications, as well as information on sociodemographic,
anthropometric, and reproductive factors. Exemption from ethical
reviewwas granted by the ethics committee of the Pirkanmaa Hospital
District (Tampere, Finland), as permitted by the Finnish regulations on
surveys. The reporting of this analysis conforms to the Strengtheningthe Reporting of Observational Studies in Epidemiology statement
(www.strobe-statement.org).
2.2. Measures
The frequency and bother of LUTSwere assessed using the questions from
the Danish Prostatic Symptom Score (DAN-PSS; Supplemental Table 1)
[21], which are consistent with the International Continence Society
deﬁnitions [1]. The DAN-PSS includes assessment of 12 LUTS: hesitancy,
weak stream, incomplete emptying, straining, daytime frequency,
nocturia, urgency, urgency urinary incontinence (UUI), pain/burning,
postmicturition dribble, stress urinary incontinence (SUI), and other
incontinence. Occurrence of most LUTS was measured on a 4-point scale
consisting of never, rarely, often, and always (Supplemental Table 1).
Bother of all LUTS was reported on a 4-point scale: none, small, moderate,
or major (Supplemental Table 1). Among symptomatic individuals
(those who reported a symptom occurring at least rarely or equivalent
were considered symptomatic; see response options in Supplemental
Table 1), the age-standardized proportion of individuals with moderate
or major bother for each LUTS was calculated to determine the individual
level of bother of each symptom. To determine the most prevalent
bother at the population level, the age-standardized prevalence of
respondents with moderate or major bother was calculated for each
symptom.
2.3. Statistical analysis
Subjects were stratiﬁed into age groups: 18–29, 30–39, 40–49, 50–59,
60–69, and 70–79 yr. Conﬁdence Interval Analysis v.2.1.2 software
(Trevor Bryant, University of Southampton, UK) was used for calculating
age-standardized prevalence and conﬁdence intervals (CIs). Other
analyses were performed with SPSS v.16.0.0 (IBM Corp., Armonk, NY,
USA). Age-standardized prevalence was based on the population
structure of Finland in early 2004. Among symptomatic individuals
and separately for both genders, the effect of age (classiﬁed as 18–39,
40–59, 60–79 yr) on bother (moderate or major vs no or small bother)
was assessed using the chi-square test for data stratiﬁed by symptom
occurrence (rarely, often, always).
3. Results
Of the 6000 men and women approached, 3727 (62.4%)
participated. Of them, 130 were excluded, resulting in 3597
respondents included in the analyses (1709 men and 1888
women) (Fig. 1). Themedian percentage of participantswho
provided information on both occurrence and bother for
each of the 12 symptoms was 95.5% (range: 91.1–97.7%) for
men and 94.3% (range: 87.9–97.5%) for women. For more
characteristics of the respondents, see Table 1.
From the population perspective, after age standardiza-
tion, the most frequent at least moderately bothersome
LUTS was urgency (7.9%), followed by SUI (6.5%), nocturia
(6.0%), postmicturition dribble (5.8%), and UUI (5.0%)
(Table 2). The population prevalence of bothersome SUI
was higher in women (12.0%; 95% CI, 10.0–13.9) than in
men (0.8%; 95% CI, 0.3–1.3) (Fig. 2; Supplemental Table 2).
Furthermore, the population burden of both UUI and
other incontinence was greater in women than in men.
There was, however, a higher population-level prevalence
of bother in men than women from voiding symptoms
(hesitancy, weak stream, and straining) and postmicturi-
tion dribble (Fig. 2; Supplemental Table 2).
[(Fig._1)TD$FIG]
Fig. 1 – Study flowchart.
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most likely to be rated as bothersome, with 30.7% of
symptomatic individuals reporting at least moderate bother
(Table 2). The degree of bother from all other symptomswasTable 1 – Age distribution and demographic characteristics among
the 1709 men and 1888 women included
Characteristics Crude
n (%)
Men Women
Age groups, yr
18–39 814 (47.6) 919 (48.7)
40–59 525 (30.7) 612 (32.4)
60–79 370 (21.7) 357 (18.9)
Marital status*
Single 382 (22.4) 368 (19.5)
Married/living together 1214 (71.0) 1256 (66.5)
Divorced/separated 79 (4.6) 145 (7.7)
Widowed 23 (1.3) 106 (5.6)
Education*
Basic level 473 (27.7) 461 (24.4)
Vocational school 577 (33.8) 574 (30.4)
College 324 (19.0) 453 (24.0)
University 327 (19.1) 376 (19.9)
Employment*
Student 172 (10.1) 255 (13.5)
Employed 1013 (59.3) 1102 (58.4)
Unemployed 110 (6.4) 131 (6.9)
Retired 389 (22.8) 375 (19.9)
Urbanity*
Nonurban 1050 (61.4) 1114 (59.0)
Urban 648 (37.9) 764 (40.5)
Body mass index, kg/m2*
<25 697 (40.8) 1061 (56.2)
25–30 759 (44.4) 537 (28.4)
30–40 207 (12.1) 199 (10.5)
40 14 (0.8) 25 (1.3)
* Information on marital status, education, employment, urbanity, and body
mass index was available for these percentages of men (women), respectively:
99.4% (99.3%), 99.5% (98.7%), 98.5% (98.7%), 99.4% (99.5%), and 98.1% (96.5%).either none or small for at least 80% of symptomatic
individuals (Fig. 3; Supplemental Table 3). The CIs of the
estimates overlapped between sexes, indicating no major
differences in the perceived bother at the individual level
between sexes (Fig. 3). In general, no major effect of age on
perceived bother was found (Supplemental Table 4).
However, rare SUI, rare UUI, and milder forms of nocturia
(one to two times per night) were perceived as less
bothersome by older than youngerwomen, and rare urgencyTable 2 – Gender-combined and age-standardized (1) prevalence
(%) of individuals reporting moderate or major bother from
different lower urinary tract symptoms (population perspective)
and (2) proportion (%) of individuals reporting moderate or major
bother among those affected with the symptom (individual
perspective)
Symptom Age-standardized prevalence/
proportion
Population
perspective, %*
Individual
perspective,%y
Hesitancy 1.6 4.6
Weak stream 1.4 16.0
Incomplete emptying 3.0 9.1
Straining 2.3 5.3
Daytime frequency 4.3 16.5
Nocturia 6.0 14.9
Urinary urgency 7.9 13.5
Urgency urinary incontinence 5.0 30.7
Pain/Burning 0.6 2.8
Postmicturition dribble 5.8 13.8
Stress urinary incontinence 6.5 19.8
Other incontinence 1.3 11.9
* The age-standardized prevalence of respondents with moderate or major
bother was calculated for each symptom.
y Among symptomatic individuals (those who reported a symptom
occurring at least rarely), the age-standardized proportion of individuals
with moderate or major bother for each lower urinary tract symptom was
calculated.
[(Fig._2)TD$FIG]
Fig. 2 – Population perspective: age-standardized prevalence (percentage) of at least moderate bother from lower urinary tract symptoms among men and
women. Error bars represent 95% confidence intervals.
[(Fig._3)TD$FIG]
Fig. 3 – Individual perspective: age-standardized proportion (percentage) of subjects reporting at least moderate bother among symptomatic men and
women. Error bars represent 95% confidence intervals.
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more bothersome for older than younger men (p < 0.05 for
all; Supplemental Table 5).
4. Discussion
Wecompared the extent towhichmen andwomen18–79 yr
of age experienced bothersome LUTS taking into accountboth population and individual perspectives. Among the
3597 participants, we observed large differences between
individual-level and population-level perspectives on
symptom bother. ‘‘No bother’’ or ‘‘minor bother’’ were
the most common responses reported for every symptom
assessed. Urgency was identified as the symptom with the
highest prevalence of at least moderate bother at the
population level. Among those who experienced a particular
E U RO P E AN URO L OGY 6 5 ( 2 0 1 4 ) 1 2 1 1 – 1 2 1 7 1215symptom, however, UUI was the symptom most likely to
be reported as bothersome. Because of its low prevalence,
UUI was only the fourth most bothersome LUTS consider-
ing the population as awhole. Differences between genders
were only observed at a population level. Women more
frequently reported bothersome SUI, whereas men more
frequently reported voiding and postmicturition symp-
toms. However, among symptomatic individuals, the
distribution of bother was similar in both genders. These
findings suggest strongly that although the etiology of
LUTSmay be different between genders, the bother impact
on individuals is similar.
4.1. Strengths and limitations
Our data provide a unique comparison of LUTS bother in a
population-based study of both genders and wide range of
adult ages. Further strengths lie both in the high response
and excellent completion rates as well as in the use of age
standardization that improves comparability with other
studies and generalizability to other populations. The
results would have been further bolstered by information
about care seeking, but current evidence suggests that only
a small proportion of women and men visit their primaryTable 3 – Overview of published English-language population-based st
symptoms*
Leicestershire
(United Kingdom)
[14]
B
(United
Data collection method Interviewer-administered
questionnaire
Maile
questi
Sample source General practice
patient list
Gener
patien
Respondents 423 2075
Response proportion, % 65.2 79.8
Sample age, yr 40–70+ 19–97
Questionnaire used Maine prostatectomy
instrument; ICS-BPH
(developmental version)
BFLUT
Total number of urinary symptoms
with bother reported
18 14
Number of urinary symptoms per
category (voiding/storage/
postmicturition/other)
6/8/2/2 4/7/1/
Symptom with greatest bother among
the affected, individual level, W
NA Noctu
Symptom with most prevalent
bother, population level, W
NA Stress
incont
Symptom with greatest bother among
the affected, individual level, M
Daytime frequency NA
Symptom with most prevalent bother,
population level, M
Terminal dribble NA
BFLUTS = Bristol Female Lower Urinary Tract Symptoms; DAN-PSS = Danish Pro
Prostatic Hyperplasia; IPSS = International Prostate Symptom Score; LUTS = lowe
* Includes population-based studies reporting on speciﬁc bother of more than ﬁv
bother combined with lower urinary tract symptoms or LUTS or urinary symptoms.
Among symptomatic subjects, the proportion of individuals with bother for each
symptom. To determine the most prevalent bother at the population level, the p
a The study deﬁned nocturia as more than two times per night.
b This information was not reported in the paper but was calculated by us.
c Urinary urgency (population level) and urgency urinary incontinence (individu
d According to the article, terminal dribble was assessed by using the question:
we consider this as postmicturition dribble.care physician with these symptoms [22–24]. Those
individuals with mild symptoms or symptoms with no or
small bother are less likely to seek care, highlighting the
importance of bother assessment. The Finnish population
has low ethnic diversity, but results are likely generalizable
to other populations of European descent with a similar
socioeconomic structure.
4.2. Comparison with other studies
We conducted a PubMed search for English-language
articles (published as of December 18, 2013) focused on
bothersomeness of LUTS (for further details, see Table 3).
Although numerous articles have been published on LUTS
[2,6,14–17,22,25–27], much fewer have also directly mea-
sured the bother from individual urinary symptoms [14–
17,25–27], and only a few of these studies were population
based [14–17]. In contrast to the present study, these earlier
population-based studies (Table 3) that assessed bother
from individual urinary symptoms have typically only
reported on a limited number of LUTS [16] or included a
limited age range [14,16,17]. Most importantly, none of the
earlier studies included both genders [14–17]. Finally, most
of the studies [15–17] did not aim to establish the mostudies assessing degree of bother from individual lower urinary tract
ristol
Kingdom)
[15]
Central Sydney
(Australia) [16]
Copenhagen and
Storstrøms
(Denmark) [17]
Finland
(present study)
d
onnaire
Telephone
interview
Mailed
questionnaire
Mailed
questionnaire
al practice
t list
Telephone
registry
Population
registry
Population
registry
340 2860 3727
65.5 71.7 62.4
40–80 40, 45, 50, 55, 60 18–79
S Modiﬁed IPSS Modiﬁed BFLUTS DAN-PSS
6 12 12
2 2/3/1/0 2/8/2/0 3/6/2/1
riaa NA Continuous
incontinenceb
Urgency urinary
incontinencec
urinary
inenceb
NA Stress urinary
incontinenceb
Stress urinary
incontinencec
Hesitancyb NA Urgency urinary
incontinencec
Postmicturition
dribbleb,d
NA Postmicturition
dribblec
static Symptom Score; ICS-BPH = International Continence Society-Benign
r urinary tract symptoms; M = men; NA = not applicable; W = women.
e LUTS, identiﬁed by PubMed search (up to December 18, 2013) with terms
LUTS was calculated to determine the individual level of bother of each
revalence of respondents with bother was calculated for each symptom.
al level) were the most bothersome when both genders were combined.
‘‘Would you ever drip a little bit of urine just as you are leaving?’’ However,
E U RO P E AN URO LOG Y 6 5 ( 2 0 1 4 ) 1 2 1 1 – 1 2 1 71216bothersome symptom at either the population or individ-
ual level but provided data enabling us to calculate the
estimates reported in Table 3. However, the heterogeneity
in sampling methods and outcome assessments from
previous population-based studies likely explain the
variability in results. Different symptoms have been
identified asmost bothersome including urgency, nocturia,
and terminal dribbling (Table 3). Among female sufferers,
storage symptoms (including incontinence) were most
likely to cause problems, whereas among male sufferers,
both storage and postmicturition symptoms were most
likely to cause problems in the international Epidemiology
of LUTS (EpiLUTS) study that evaluated prevalence and
bother of numerous LUTS [26,28]. As many as 88 150
individuals were contacted mainly from consumer panels
(self-selected volunteers and cannot be regarded as
population based), and a final sample of 30 000 was
evaluated. The comparison of the relative adverse impact
(individual perspective) of LUTS was similar between
(EpiLUTS) and our study. Overall, in our study, urgencywas
the symptom most frequently found bothersome at the
population level. Of those who were symptomatic,
individuals reporting UUI most frequently found the
symptom at least moderately bothersome.
4.3. Implications of the findings
From the population perspective, this study identifies
urgency as the most pressing public health priority across
both genders, a situation reflected in the current major
interest in so-called overactive bladder syndrome [29]. For
women, SUI is and should be a major priority, with a high
prevalence of bothersome symptoms (12% of women).
Notably, 7.5% of all women reported UUI with moderate or
major bother, and 6% reported nocturia with moderate or
major bother. In contrast, for men most current interest
focuses on storage symptoms, and although both bother-
some urgency and nocturia were highly prevalent (6.8% and
6.0% of men, respectively), these data suggest that post-
micturition dribble (7.7% of men) may be an overlooked
area for investigation and funding.
Among symptomatic individuals in both genders, we
found that UUI was the symptom most likely to cause
moderate or major bother. This is consistent with previous
studies that suggest substantial impacts of UUI on quality of
life and strong associations with anxiety and depression [3].
Clinicians should be aware of the differing impacts of each
subtype of incontinence for women, and question patients
carefully regarding the extent of bother, managing patients
according to their responses.
Overall treatment compliance with many medications
for benign prostatic hyperplasia is suboptimal and espe-
cially poor for medications for overactive bladder syn-
drome, even in comparison with long-term medications for
hypercholesterolemia or osteoporosis [30,31]. We found
that only a minority of men or women who reported any
symptom had substantial bother. The high prevalence of
these symptoms, therefore, does not imply large unmet
demand for therapy. Our results suggest that most LUTS arewell tolerated across ages and genders, partly probably due
to their fluctuating nature [32,33], and therefore they
highlight the importance of bother assessment in clinical
practice, especially before invasive diagnostics or initiation
of therapy.
5. Conclusions
Urinary urgency is the most prevalent bothersome LUTS
at a population level, but of individuals with symptoms,
UUI is most likely to be rated as bothersome. We observed
substantial differences in the frequency of symptoms inmen
and women, but for symptomatic subjects, the frequency of
at least moderate bother was similar.
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